Effects of repetitive functional magnetic stimulation in the sacral nerve in patients with neurogenic detrusor overactivity after suprasacral spinal cord injury: a study protocol for a randomized controlled trial

Effects of repetitive functional magnetic stimulation in the sacral nerve in patients with neurogenic detrusor overactivity after suprasacral spinal cord injury: a study protocol for a randomized controlled trial

Abstract Background Neurogenic detrusor overactivity (NDO) is a serious and common complication after spinal cord injury, affecting patients’ quality of life seriously. Therefore, we developed this research protocol to evaluate the efficacy of repetitive functional magnetic stimulation (rFMS) in the...

Full description

Bibliographic Details
Main Authors:	Jiyang Li, Jianxiong Wang, Yue Hu, Rui Jian, Yulu Zhao, Dan Li, Tenggang Wan, Wuga Jike, Fangyuan Xu, Maomao Huang
Format:	Article
Language:	English
Published:	BMC 2023-03-01
Series:	Trials
Subjects:	Neurogenic detrusor overactivity Repetitive functional magnetic stimulation Spinal cord injury Bladder function Physiotherapy Randomized controlled trial
Online Access:	https://doi.org/10.1186/s13063-023-07207-1

Similar Items

Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
by: Chung-Cheng Wang, et al.
Published: (2021-12-01)

Adverse Effects of Intravesical OnabotulinumtoxinA Injection in Patients with Idiopathic Overactive Bladder or Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Studies
by: Ping-Hsuan Yu, et al.
Published: (2024-08-01)

Investigating Urine Biomarkers in Detrusor Underactivity and Detrusor Overactivity with Detrusor Underactivity Patients
by: Yuan-Hong Jiang, et al.
Published: (2023-04-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Effect of Memantine on Overactive Detrusor in Rats With Spinal Cord Injury
by: Cüneyd Özkürkçügil, et al.
Published: (2010-05-01)

Concomitant Botulinum Toxin Injections for Neurogenic Detrusor Overactivity and Spasticity—A Retrospective Analysis of Practice and Safety
by: Arnaud Leilaz, et al.
Published: (2024-05-01)

Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?
by: Amélie Huynh Le Maux, et al.
Published: (2015-12-01)

Patient treatment preferences for symptomatic refractory urodynamic idiopathic detrusor overactivity
by: Christina L Fontaine, et al.
Published: (2017-01-01)

Low-count bacteriuria in refractory idiopathic detrusor overactivity versus controls
by: Colin Walsh, et al.
Published: (2011-07-01)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
by: Aida Javan Balegh Marand, et al.
Published: (2023-05-01)

Short-term outcome of onabotulinumtoxin A injection for the treatment of refractory idiopathic detrusor overactivity
by: Gamal E A. Abourjila, et al.
Published: (2020-01-01)

Role of percutaneous tibial nerve stimulation in the management of the detrusor overactivity
by: Emad K El Tair, et al.
Published: (2022-01-01)

Response to Treatment with Botulinum Neurotoxin A (BoNT-A) in Children and Adolescents with Neurogenic Lower Urinary Tract Dysfunction and Idiopathic Overactive Bladder: A Systematic Review and Meta-Analysis
by: Andrea Panunzio, et al.
Published: (2024-10-01)

Predicting Refractory Detrusor Overactivity: Are There any Clues at Diagnosis
by: Kylie J Mansfield, et al.
Published: (2013-12-01)

Effectiveness of onabotulinumtoxin A for refractory overactive bladder with cough‐associated detrusor overactivity
by: Chie Nakai, et al.
Published: (2024-05-01)

Long term safety outcomes and continuation rates of repeated Intravesical Botulinum Toxin A injections for Detrusor Overactivity: 16 year’s experience of a Tertiary Centre in the UK
by: R. Mohamed-Ahmed, et al.
Published: (2024-03-01)

Long-term follow-up of intravesical abobotulinumtoxinA (Dysport®) injections in women with idiopathic detrusor overactivity
by: Mohammad Sajjad Rahnama'i, et al.
Published: (2024-01-01)

Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivity
by: Quentin Ballouhey, et al.
Published: (2015-12-01)

Peripheral repetitive magnetic stimulation for the treatment of neurogenic urinary disorders: literature review and investigational study
by: I. V. Borodulina, et al.
Published: (2017-09-01)

Hyperactive bladder: concept of disease and paradigms in the treatment
by: G. G. Krivoborodov, et al.
Published: (2021-04-01)

Taiwanese Continence Society clinical guidelines for diagnosis and management of neurogenic lower urinary tract dysfunction
by: Hann-Chorng Kuo, et al.
Published: (2014-06-01)

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
by: Hann-Chorng Kuo
Published: (2020-06-01)

The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia
by: Tomonori Yamanishi, et al.
Published: (2015-06-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

A Urodynamic Comparison of Neural Targets for Transcutaneous Electrical Stimulation to Acutely Suppress Detrusor Contractions Following Spinal Cord Injury
by: Sean Doherty, et al.
Published: (2019-12-01)

Strategies for Safe Transurethral Injections of Botulinum Toxin into the Bladder Wall
by: Matthias Oelke
Published: (2024-06-01)

Significance of preoperatively observed detrusor overactivity as a predictor of continence status early after robot-assisted radical prostatectomy
by: Akihiro Yanagiuchi, et al.
Published: (2014-12-01)

Detrusor Overactivity After Partial Bladder Outlet Obstruction Is Associated With High Urinary Adenosine Triphosphate Levels in Female Wistar Rats
by: Luís Vale, et al.
Published: (2024-02-01)

Challenges and practical considerations in delivering botulinum neurotoxin to adults with congenital neurogenic lower urinary tract dysfunction with history of genitourinary reconstruction
by: Johnny S. Su, et al.
Published: (2024-09-01)

Surgical Outcomes and Predictive Factors in Patients With Detrusor Underactivity Undergoing Bladder Outlet Obstruction Surgery
by: Ming-Syun Chuang, et al.
Published: (2024-03-01)

Childhood nocturnal enuresis and clinical course of overactive bladder in women
by: Igor V. Kuzmin, et al.
Published: (2024-10-01)

Assessing the Use of BotulinumtoxinA for Hyperactive Urinary Tract Dysfunction a Decade After Approval: General Versus Local Anesthesia for BotulinumtoxinA Detrusor Injection
by: Heinrich Schulte-Baukloh, et al.
Published: (2024-10-01)

Bladder ultrasonography for diagnosing detrusor overactivity: test accuracy study and economic evaluation
by: Suneetha Rachaneni, et al.
Published: (2016-01-01)

Transcutaneous posterior tibial nerve stimulation on demand during multichannel urodynamics: A new approach in the management of overactive bladder
by: Javier A. Muñoz, et al.
Published: (2024-06-01)

Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection in Patients with Detrusor Hyperactivity and Impaired Contractility
by: Chung-Cheng Wang, et al.
Published: (2016-03-01)

The use of ultrasound-estimated bladder weight in diagnosing bladder outlet obstruction and detrusor overactivity in men with lower urinary tract symptoms
by: Fadi Housami, et al.
Published: (2009-01-01)

The peptide regulator Vezusten in the management of overactive bladder syndrome: an efficacy evaluation
by: G. V. Kovalev, et al.
Published: (2024-09-01)

Bladder contractility index changes with short-term antimuscarinic therapy in patients with detrusor overactivity: A placebo controlled randomised study
by: Alka Ashok Bhide, et al.
Published: (2023-12-01)

Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study
by: Djamel Bensmail, et al.
Published: (2023-04-01)

Long-term Outcome of Infants with Spina Bifida Through Assessment of the Prognostic Value of Hostile Bladder Parameters
by: Ali Tekin, et al.
Published: (2021-06-01)